Ciba Vision Ophthalmics (US) and Quadra Logic Technologies (Canada) forge photodynamic therapy (PDT) agreement
This article was originally published in Clinica
Executive Summary
Ciba Vision Ophthalmics (US) and Canadian company Quadra Logic Technologies will develop and commercialise photodynamic therapy (PDT) for treating eye disease. Ciba Vision will fund 60% of development costs while profits from sales of resulting products will be shared equally.